Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹26,397.3
₹56,093 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,879.7
₹35,977 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹494.4
₹7,781 Cr
Pharmaceuticals & Drugs
₹638.9
₹5,792 Cr
Pharmaceuticals & Drugs
₹340.8
₹3,110 Cr
Pharmaceuticals & Drugs
₹274.3
₹3,070 Cr
Pharmaceuticals & Drugs
₹79.3
₹2,036 Cr
Pharmaceuticals & Drugs
₹650.0
₹371 Cr
Pharmaceuticals & Drugs
₹62.1
₹176 Cr
Pharmaceuticals & Drugs
₹30.0
₹146 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,879.7
₹5,202 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹494.4
₹4,257 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹340.8
₹2,522 Cr
Pharmaceuticals & Drugs
₹638.9
₹1,801 Cr
Pharmaceuticals & Drugs
₹274.3
₹710 Cr
Pharmaceuticals & Drugs
₹79.3
₹240 Cr
Pharmaceuticals & Drugs
₹30.0
₹129 Cr
Pharmaceuticals & Drugs
₹26,397.3
₹6,824 Cr
Pharmaceuticals & Drugs
₹650.0
₹323 Cr
Pharmaceuticals & Drugs
₹62.1
₹391 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,879.7
₹1,015 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹494.4
₹325 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹638.9
₹211 Cr
Pharmaceuticals & Drugs
₹340.8
₹202 Cr
Pharmaceuticals & Drugs
₹274.3
₹155 Cr
Pharmaceuticals & Drugs
₹79.3
₹140 Cr
Pharmaceuticals & Drugs
₹30.0
₹5 Cr
Pharmaceuticals & Drugs
₹26,397.3
₹1,524 Cr
Pharmaceuticals & Drugs
₹650.0
₹10 Cr
Pharmaceuticals & Drugs
₹62.1
₹3 Cr

You may also like the below Video Courses